Liquid biopsy: an innovative and reliable method for detecting not only somatic, but also germline mutations in patients with colorectal and non-small cell lung carcinoma

Liquid biopsy is a non-invasive method of detecting cancer-related mutations from circulating cell-free DNA (cfDNA) and has emerged as a promising alternative to traditional tissue biopsies. However, its utility has so far been limited to the detection of somatic mutations in cancer cells. Our study...

Full description

Bibliographic Details

Published in:	Biotechnology & Biotechnological Equipment
Main Authors:	Nelly Miteva-Marcheva, Hristo Ivanov, Veselin Popov, Gabriela Raycheva, Zhanet Grudeva-Popova, Vili Stoyanova
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-03-01
Subjects:	Liquid biopsy germline mutations pharmacogenetics colorectal cancer non-small cell lung carcinoma
Online Access:	https://www.tandfonline.com/doi/10.1080/13102818.2023.2249560